Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in chil...
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial
About this item
Full title
Author / Creator
N'Goran, Eliézer K , Odiere, Maurice R , Assandé Aka, Ronald , Ouattara, Mamadou , Aka, N A David , Ogutu, Bernhards , Rawago, Fredrick , Bagchus, Wilhelmina M , Bödding, Matthias , Kourany-Lefoll, Elly , Tappert, Aliona , Yin, Xiaoyan , Bezuidenhout, Deon , Badenhorst, Henk , Huber, Eric , Dälken, Benjamin and Haj-Ali Saflo, Okba
Publisher
United States: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
WHO has underlined the need for a child-friendly treatment for schistosomiasis, a prevalent parasitic disease in low-income and middle-income countries. After successful phase 1 and 2 trials, we aimed to evaluate the efficacy, safety, palatability, and pharmacokinetics of arpraziquantel (L-praziquantel) orodispersible tablets for preschool-aged chi...
Alternative Titles
Full title
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2786101687
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2786101687
Other Identifiers
ISSN
1473-3099,1474-4457
E-ISSN
1474-4457
DOI
10.1016/S1473-3099(23)00048-8
